É. Martin

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Karim Fizazi, Stéphanie Foulon, Joan Carles et al. · The Lancet · 2022 · 716 citations · Full text

Factorial Design, Urology, × 2 +9

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases

Jérôme Fayette, É. Martin, Sophie Piperno‐Neumann et al. · Annals of Oncology · 2007 · 391 citations · Full text

Primary Site, Retrospective Study, Surgical Pathology +3

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ¹⁸F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Pierre Véra, S. Thureau, Philippe Chaumet‐Riffaud et al. · Journal of Nuclear Medicine · 2017 · 81 citations · Full text

Salvage extended field or involved field nodal irradiation in 18F-fluorocholine PET/CT oligorecurrent nodal failures from prostate cancer

A. Lépinoy, Yannick E. Silva, É. Martin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 51 citations

Engineering, Radiation Therapy, Molecular Imaging +6

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer

G. Créhange, Céline Mirjolet, Mélanie Gauthier et al. · Radiotherapy and Oncology · 2011 · 50 citations

Urology, Engineering, Health Sciences +13